NEW YORK (GenomeWeb) – CombiMatrix reported after the close of the market Thursday that its first quarter revenues climbed 27 percent driven by an uptick in its reproductive health test sales.

The Irvine, California-based molecular diagnostics firm reported total revenues of $3.8 million, up from $3 million in the first quarter of 2016. It noted that its reproductive health test sales were up 32 percent year over year to $2.9 million, while volume for such tests were up 15 percent to 1,642 in the quarter. Its total test volume increased 11 percent year over year to 2,938.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.